Cells make a lot of trash. Probably more than you’d think. So, cells have a trash disposal system that efficiently cleans up and recycles any waste that is produced. But when there are issues with the disposal system and trash builds up in the cell, that can lead to disease. This has led researchers to consider the trash disposal system as a target for potential disease treatments and therapies.
Charcot-Marie-Tooth Disease
Charcot-Marie-Tooth Disease News
John Svaren honored with Vilas professorship
Professor of Comparative Biosciences at the School of Veterinary Medicine and Waisman Center investigator, John Svaren, PhD, is a recipient of a Vilas Distinguished Professorship.
Waisman’s Own Takes Interim Position in OVCRGE
CMT is a slowly progressive disease in contrast to ALS, which affects the same neurons in the peripheral nervous system.
Neurodegeneration research at the Waisman Center from gene to organelle to cell to brain
Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth disease, and retinitis pigmentosa all have different manifestations and affect different body functions, but they are all connected by one mechanism: neurodegeneration.
John Svaren joins research office leadership team
John Svaren, professor of Comparative Biosciences at the School of Veterinary Medicine and director of the Waisman Center IDD Models Core, has been named the interim Associate Vice Chancellor for Research in the Biological Sciences.
Artificial intelligence: A real tool for advancing research on intellectual and developmental disabilities and beyond
AI collects big data and uses computer algorithms to search patterns that are present in your daily life.
Cells with a superhero alter ego: Schwann cells transform into repair cells after nerve injury with help of transcription factor JUN and Sonic Hedgehog gene
When nerves are injured, Schwann cells—a key cell in peripheral nerve function and nerve insulation—assume a new role and identity as repair cells.
CMT biomarkers for future treatments
A new test may spur advances in drug discovery for a rare and debilitating neurological disorder. Charcot-Marie-Tooth disease, a rare inherited neurological disorder, affects more than 2.8 million people around the globe.
The identities of enzymes: study further defines the function of a potential target for Alzheimer’s therapy
A new study from the lab of UW-Madison professor of medicine Luigi Puglielli, MD, PhD, opens a door to potential treatments for diseases of age, such as Alzheimer’s disease, by defining the roles of two enzymes that are imperative to protein production.
CMT advocate will not be sidelined
CMT is equally common among all ages, genders, and races and is one of the most common heritable neurological impairments. The symptoms present as neuropathy, foot drop, poor balance, difficulty with dexterity, or abnormal sensation – just to name a few.